BLACR Stock Ownership Activity

BELLEVUE LIFE SCIENCES-RTS 13F holders

No value investing guru has made any change to the BELLEVUE LIFE SCIENCES-RTS (BLACR) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying BLACR now?

According to the latest SEC filing(s) BELLEVUE LIFE SCIENCES-RTS (BLACR) has not been purchased by any super investor.

To see more about who is investing in BELLEVUE LIFE SCIENCES-RTS (BLACR), please go to the BLACR ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2023 Q2 (1 result)
Howard Marks
Oaktree Capital Management
-100.00%
-145,250
-0.00%
0.00%
Reported price*: $0.16
2023 Q1 (1 result)
Howard Marks
Oaktree Capital Management
buy
+145,250
+0.00%
0.00%
Reported price*: $0.16
2 of 2

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.